tradingkey.logo
tradingkey.logo
Search

Abivax Announces Presentation Of Late-Breaking Abstract For Obefazimod From Abtect Phase 3 Induction Trials At 2025 UEG Meeting

ReutersSep 23, 2025 10:29 PM
facebooktwitterlinkedin
View all comments0

- Abivax SA ABVX.PA:

  • ABIVAX ANNOUNCES PRESENTATION OF LATE-BREAKING ABSTRACT FOR OBEFAZIMOD FROM THE ABTECT PHASE 3 INDUCTION TRIALS AT 2025 UNITED EUROPEAN GASTROENTEROLOGY (UEG) MEETING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI